Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8725320 [patent_doc_number] => 08404435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Enigma-Mdm2 interaction and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/240351 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 62 [patent_no_of_words] => 11507 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13240351 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/240351
Enigma-Mdm2 interaction and uses thereof Sep 21, 2011 Issued
Array ( [id] => 7744176 [patent_doc_number] => 20120021945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma' [patent_app_type] => utility [patent_app_number] => 13/224102 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20823 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021945.pdf [firstpage_image] =>[orig_patent_app_number] => 13224102 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/224102
Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma Aug 31, 2011 Abandoned
Array ( [id] => 8126731 [patent_doc_number] => 20120087918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH OF HEMATOPOIETIC MALIGNANT CELLS' [patent_app_type] => utility [patent_app_number] => 13/220307 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 17847 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087918.pdf [firstpage_image] =>[orig_patent_app_number] => 13220307 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/220307
Methods and compositions for inhibiting the growth of hematopoietic malignant cells Aug 28, 2011 Issued
Array ( [id] => 11199378 [patent_doc_number] => 09429582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker' [patent_app_type] => utility [patent_app_number] => 13/819940 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 19 [patent_no_of_words] => 20954 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819940 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/819940
Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker Aug 24, 2011 Issued
Array ( [id] => 8637089 [patent_doc_number] => 20130028893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'Therapeutic antibodies with reduced side effect' [patent_app_type] => utility [patent_app_number] => 13/199127 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4400 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199127 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/199127
Therapeutic antibodies with reduced side effect Aug 18, 2011 Abandoned
Array ( [id] => 7669494 [patent_doc_number] => 20110318763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2' [patent_app_type] => utility [patent_app_number] => 13/205095 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21143 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205095 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/205095
DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2 Aug 7, 2011 Abandoned
Array ( [id] => 8994770 [patent_doc_number] => 08518654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect' [patent_app_type] => utility [patent_app_number] => 13/197849 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 11 [patent_no_of_words] => 9365 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197849 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/197849
Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect Aug 3, 2011 Issued
Array ( [id] => 8828668 [patent_doc_number] => 20130129713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHOD OF ANTIGEN LOADING FOR IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/813778 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 14999 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813778 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/813778
METHOD OF ANTIGEN LOADING FOR IMMUNOTHERAPY Aug 3, 2011
Array ( [id] => 7651790 [patent_doc_number] => 20110301059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Biomarkers For Human Papilloma Virus-Associated Cancers' [patent_app_type] => utility [patent_app_number] => 13/194624 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15042 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301059.pdf [firstpage_image] =>[orig_patent_app_number] => 13194624 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/194624
Biomarkers for human papilloma virus-associated cancers Jul 28, 2011 Issued
Array ( [id] => 9263394 [patent_doc_number] => 20130345322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'DIAGNOSTIC FOR COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/809785 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12554 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809785 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/809785
DIAGNOSTIC FOR COLORECTAL CANCER Jul 13, 2011 Abandoned
Array ( [id] => 7656361 [patent_doc_number] => 20110305630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/168129 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11885 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305630.pdf [firstpage_image] =>[orig_patent_app_number] => 13168129 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/168129
MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS Jun 23, 2011 Abandoned
Array ( [id] => 7755583 [patent_doc_number] => 20120028269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Methods For Detection Of Gastric Cancer' [patent_app_type] => utility [patent_app_number] => 13/156782 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12367 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028269.pdf [firstpage_image] =>[orig_patent_app_number] => 13156782 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/156782
Methods for detection of gastric cancer Jun 8, 2011 Issued
Array ( [id] => 8854236 [patent_doc_number] => 20130143911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/701889 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29675 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701889 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/701889
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors Jun 8, 2011 Abandoned
Array ( [id] => 7651290 [patent_doc_number] => 20110300559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1' [patent_app_type] => utility [patent_app_number] => 13/152271 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17731 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300559.pdf [firstpage_image] =>[orig_patent_app_number] => 13152271 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/152271
Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1 Jun 2, 2011 Issued
Array ( [id] => 10025052 [patent_doc_number] => 09066930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Activin receptor-like kinase-1 compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 13/112954 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 43 [patent_no_of_words] => 43526 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112954 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112954
Activin receptor-like kinase-1 compositions and methods of use May 19, 2011 Issued
Array ( [id] => 8755567 [patent_doc_number] => 20130089872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO' [patent_app_type] => utility [patent_app_number] => 13/698201 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 34835 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698201 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/698201
Anti-human TROP-2 antibody having anti-tumor activity in vivo May 16, 2011 Issued
Array ( [id] => 8066089 [patent_doc_number] => 20110243974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/109976 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17878 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243974.pdf [firstpage_image] =>[orig_patent_app_number] => 13109976 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/109976
Tumor antigen protein SART-3 and tumor antigen peptides thereof May 16, 2011 Issued
Array ( [id] => 7582661 [patent_doc_number] => 20110296544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'COLON CANCER TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/108674 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66441 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0296/20110296544.pdf [firstpage_image] =>[orig_patent_app_number] => 13108674 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/108674
COLON CANCER TARGETS AND USES THEREOF May 15, 2011 Abandoned
Array ( [id] => 8814567 [patent_doc_number] => 20130115612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS' [patent_app_type] => utility [patent_app_number] => 13/696404 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11907 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696404 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/696404
METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS May 5, 2011 Abandoned
Array ( [id] => 9477174 [patent_doc_number] => 20140134637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/092770 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14759 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13092770 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/092770
METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER Apr 21, 2011 Abandoned
Menu